Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Development of the Heart01:27

Development of the Heart

3.9K
The development of the human heart, a crucial organ, commences from the mesoderm on the 18th or 19th day after fertilization. This process initiates in the cardiogenic area, a group of mesodermal cells at the embryo's head end, which evolves into elongated strands known as cardiogenic cords. These cords undergo a transformation to form hollow-centered endocardial tubes.
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
3.9K
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

1.7K
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.7K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

785
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
785
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

4.6K
Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.6K
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

2.2K
Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
2.2K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

1.5K
Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: SIRT7 activates p53 by enhancing PCAF-mediated MDM2 degradation to arrest the cell cycle.

Oncogene·2026
Same author

Alexithymia of nursing students in higher vocational college: application of latent profile analysis and network analysis.

Frontiers in psychiatry·2026
Same author

Machine learning-based retrieval of total nitrogen matter from an inland highly turbid lake using Landsat 8 OLI Imagery.

Environmental monitoring and assessment·2026
Same author

Spectral CT quantification of organ mass and physical density: A non-invasive metric for assessing functional reserve in type 2 diabetes.

The International journal of artificial organs·2026
Same author

Eco-Friendly Low-Cost Design of Superhydrophobic Cu Mesh for Efficient Oil-Water Separation.

Molecules (Basel, Switzerland)·2026
Same author

Differentiation of arterioles and capillaries in human blood vessel organoids with decellularized splenic matrix.

Bioactive materials·2026
Same journal

Cryogel-based therapeutic platforms for disease modification in osteoarthritis.

npj biomedical innovations·2026
Same journal

Ancestry-linked IL-10 signaling and macrophage activation modulate fibroblast responses to oxidative stress in a PEG-based microphysiological system.

npj biomedical innovations·2026
Same journal

In vitro modeling of inflammatory bowel diseases using a newly developed immunocompetent colon epithelial monolayer co-culture model.

npj biomedical innovations·2026
Same journal

Focused ultrasound-induced cavitation in a human brain microphysiological system produces injury signaling biomarkers consistent with blast trauma.

npj biomedical innovations·2026
Same journal

Human colon organoid Transwell model for investigating epithelial growth and repair.

npj biomedical innovations·2026
Same journal

Development and early feasibility testing of machine-learning algorithms to non-invasively assess hemoglobin levels.

npj biomedical innovations·2026
See all related articles

Related Experiment Video

Updated: Apr 26, 2026

Capturing the Cardiac Injury Response of Targeted Cell Populations via Cleared Heart Three-Dimensional Imaging
08:14

Capturing the Cardiac Injury Response of Targeted Cell Populations via Cleared Heart Three-Dimensional Imaging

Published on: March 17, 2020

5.3K

Rejuvenating the damaged and aged heart: lessons from development.

Ge Liu1, Hanchao Gao1, Xinyu Liu2

  • 1Department of Geriatric Medicine, Shenzhen Longhua District Central Hospital, Shenzhen, China.

Npj Biomedical Innovations
|April 24, 2026
PubMed
Summary
This summary is machine-generated.

Mammals lose heart regeneration for strong contractions. Reactivating juvenile cell growth pathways may restore cardiac repair in aging hearts.

More Related Videos

Myocardial Infarction in Neonatal Mice, A Model of Cardiac Regeneration
07:48

Myocardial Infarction in Neonatal Mice, A Model of Cardiac Regeneration

Published on: May 24, 2016

19.0K
Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

6.8K

Related Experiment Videos

Last Updated: Apr 26, 2026

Capturing the Cardiac Injury Response of Targeted Cell Populations via Cleared Heart Three-Dimensional Imaging
08:14

Capturing the Cardiac Injury Response of Targeted Cell Populations via Cleared Heart Three-Dimensional Imaging

Published on: March 17, 2020

5.3K
Myocardial Infarction in Neonatal Mice, A Model of Cardiac Regeneration
07:48

Myocardial Infarction in Neonatal Mice, A Model of Cardiac Regeneration

Published on: May 24, 2016

19.0K
Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes
09:16

Suppression of Pro-fibrotic Signaling Potentiates Factor-mediated Reprogramming of Mouse Embryonic Fibroblasts into Induced Cardiomyocytes

Published on: June 3, 2018

6.8K

Area of Science:

  • Cardiovascular Biology
  • Developmental Biology
  • Regenerative Medicine

Background:

  • Mammals exhibit limited cardiac regeneration due to an evolutionary trade-off for high-output contractile function.
  • Cardiomyocyte cell-cycle withdrawal is regulated by metabolic, epigenetic, and microenvironmental factors during development.

Purpose of the Study:

  • To explore strategies for restoring cardiomyocyte proliferative potential in adult mammals.
  • To investigate the potential of reprogramming juvenile regulatory networks to enhance cardiac regeneration.

Main Methods:

  • Induction of specific transcription factors.
  • Metabolic reprogramming of cardiomyocytes.
  • Modulation of the cardiac cellular niche.

Main Results:

  • Juvenile regulatory networks hold potential for restoring proliferative capacity in adult cardiomyocytes.
  • Cardiac aging mirrors developmental disruptions in regenerative mechanisms.

Conclusions:

  • Reprogramming strategies targeting developmental barriers may counteract cardiac senescence.
  • Restoring regenerative potential is a promising therapeutic avenue for aging hearts.